These results suggest that NCAPD3 may act as a checkpoint in cellular bioenergetic pathways; however, its potential roles in these pathways may be different between tumor-derived cells and primary cells, which have very different metabolic needs (Vander Heiden et al., 2009; Boland et al., 2013). Here, NCAPD3 is linked to neoplasm.